Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study.
Fujimoto A, Koutake Y, Hisamatsu D, Ookubo N, Yabuuchi Y, Kamimura G, Kai T, Kozono A, Ootsu T, Suzuki H, Matsuo K, Kuwahara K, Oiwane Y, Nagata Y, Tanimoto K, Sato E, Suenaga M, Uehara T, Ikari A, Endo S, Hiraki Y, Kawamata Y.
Fujimoto A, et al. Among authors: koutake y.
Cancer Immunol Immunother. 2023 Jul;72(7):2169-2178. doi: 10.1007/s00262-023-03408-4. Epub 2023 Feb 27.
Cancer Immunol Immunother. 2023.
PMID: 36849845
Free PMC article.